Metabolism and cancer-select topics
Metabolism and Target Organ Damage · 2022
DOI: 10.20517/mtod.2022.05 ↗Kurz gefasst
Fachartikel in der Zeitschrift Metabolism and Target Organ Damage, 2022. Verfasst von Fulvio Lonardo und 1 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref).
Abstract (Originalsprache)
Metabolism and cancer intersect in multiple ways. Cancer has unique metabolic properties, including an inordinate reliance on anaerobic glycolysis (the Warburg effect). From an evolutionary standpoint, increased cancer incidence is associated with increased metabolic rates across species. Epidemiological data prove that a group of overlapping metabolic alterations, including obesity, type II Diabetes Mellitus, non-alcoholic fatty liver disease, and metabolic syndrome, constitute predisposing risk factors for cancer development in multiple anatomical sites. The molecular pathways underpinning this association involve hyperinsulinemia, hyperglycemia, sex hormones, adipokines, chronic inflammation, oxidative stress, and altered immune response.
Zitieren
APA
Lonardo, F., & Ballouk, C. (2022). Metabolism and cancer-select topics. Metabolism and Target Organ Damage. https://doi.org/10.20517/mtod.2022.05
Vancouver
Lonardo F, Ballouk C. Metabolism and cancer-select topics. Metabolism and Target Organ Damage. 2022. doi:10.20517/mtod.2022.05
BibTeX
@article{Lonardo2022,
author = {Lonardo, Fulvio and Ballouk, Casem},
title = {Metabolism and cancer-select topics},
journal = {Metabolism and Target Organ Damage},
year = {2022},
doi = {10.20517/mtod.2022.05}
}
EUVIMED